Clinical Trials Directory

Trials / Completed

CompletedNCT01922778

Screening for Endometrial Abnormalities in Overweight and Obese Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
303 (actual)
Sponsor
St. Luke's-Roosevelt Hospital Center · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to develop an endometrial biopsy screening program for endometrial cancer and its precursor lesions in overweight and obese women. There is a BMI threshold at and above which optimal screening parameters exist for identifying endometrial cancer and its precursor lesions in overweight and/or obese women. Prevention, diagnosis and treatment of endometrial cancer and its precursor lesions in overweight and/or obese women offers substantial health benefits.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndometrial BiopsyRecruits from the Bariatric Surgery Program will be interviewed by a study investigator prior to their bariatric surgery. During the interview, the purpose of the study will be explained as well as the surgical technique used for obtaining an endometrial sample. If the patient consents to the procedure, then this will usually be a D\&C performed in one setting at the time of her bariatric surgery under general anesthesia. In the case where a patient is diagnosed with complex atypical endometrial hyperplasia or early endometrial prior to her bariatric surgery, an IUD can be inserted at the time of her bariatric surgery. For patients not undergoing bariatric surgery, an endometrial biopsy will be performed in the clinic or office setting using an endometrial suction catheter.

Timeline

Start date
2013-09-01
Primary completion
2016-03-31
Completion
2016-03-31
First posted
2013-08-14
Last updated
2017-07-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01922778. Inclusion in this directory is not an endorsement.